ARK Investment Management’s Redhill Biopharma RDHL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,045	Closed	-$1.17M	–	317
2022 Q2	$1.17M	Buy	1,045 +183	+21%	+$251K	0.01%	232
2022 Q1	$2.17M	Buy	+862	New	+$2.04M	0.01%	218
2021 Q4	–	Sell	-19	Closed	-$88K	–	373
2021 Q3	$88K	Sell	19 -768	-98%	-$5.21M	﹤0.01%	293
2021 Q2	$5.42M	Buy	787 +11	+1%	+$75.9K	0.01%	220
2021 Q1	$5.68M	Buy	776 +609	+365%	+$5.11M	0.01%	209
2020 Q4	$1.35M	Buy	167 +44	+36%	+$396K	﹤0.01%	202
2020 Q3	$1.26M	Sell	123 -23	-16%	-$189K	0.01%	144
2020 Q2	$979K	Buy	146 +50	+52%	+$344K	0.01%	162
2020 Q1	$436K	Buy	96 +38	+66%	+$190K	0.01%	138
2019 Q4	$354K	Buy	58 +2	+4%	+$12.8K	0.01%	172
2019 Q3	$393K	Sell	56 -4	-7%	-$29.1K	0.01%	167
2019 Q2	$389K	Sell	60 -6	-9%	-$46.2K	0.01%	160
2019 Q1	$548K	Buy	66 +5	+8%	+$39.6K	0.02%	119
2018 Q4	$337K	Buy	61 +12	+24%	+$91.9K	0.01%	140
2018 Q3	$434K	Sell	49 -64	-57%	-$521K	0.01%	153
2018 Q2	$961K	Buy	113 +9	+9%	+$57.2K	0.04%	104
2018 Q1	$534K	Buy	104 +75	+259%	+$432K	0.03%	130
2017 Q4	$149K	Buy	+29	New	+$195K	0.01%	159